The stock of Metlife Inc (NYSE:MET) hit a new 52-week high and has $56.59 target or 3.00% above today’s $54.94 share price. The 7 months bullish chart indicates low risk for the $60.42 billion company. The 1-year high was reported on Nov, 23 by Barchart.com. If the $56.59 price target is reached, the company will be worth $1.81B more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 2.25M shares traded hands. Metlife Inc (NYSE:MET) has risen 18.84% since April 21, 2016 and is uptrending. It has outperformed by 13.51% the S&P500.
Analysts await Metlife Inc (NYSE:MET) to report earnings on February, 1. They expect $1.35 EPS, up 9.76% or $0.12 from last year’s $1.23 per share. MET’s profit will be $1.48B for 10.17 P/E if the $1.35 EPS becomes a reality. After $1.28 actual EPS reported by Metlife Inc for the previous quarter, Wall Street now forecasts 5.47% EPS growth.
Metlife Inc (NYSE:MET) Ratings Coverage
Out of 12 analysts covering MetLife (NYSE:MET), 7 rate it a “Buy”, 0 “Sell”, while 5 “Hold”. This means 58% are positive. MetLife has been the topic of 16 analyst reports since July 31, 2015 according to StockzIntelligence Inc. Deutsche Bank maintained the stock with “Buy” rating in Friday, July 31 report. Morgan Stanley downgraded it to “Equal-Weight” rating and $56 target price in Wednesday, November 11 report. As per Thursday, January 14, the company rating was upgraded by Macquarie Research. As per Wednesday, July 13, the company rating was downgraded by Deutsche Bank. The rating was downgraded by Citigroup to “Neutral” on Tuesday, January 5. FBR Capital maintained the stock with “Outperform” rating in Monday, August 29 report. The firm has “Outperform” rating given on Friday, September 23 by Wells Fargo. The rating was maintained by RBC Capital Markets with “Outperform” on Tuesday, January 19. The firm earned “Strong Buy” rating on Friday, January 22 by Raymond James. The firm earned “Buy” rating on Monday, June 27 by Sandler O’Neill.
According to Zacks Investment Research, “Metlife Inc. is a leading provider of insurance and financial services to a broad spectrum of individual and institutional customers. The company currently provides individual insurance, annuities and investment products. The company also provides group insurance and retirement and savings products and services to corporations and other institutions. The company believes that their unparalleled franchises and brand names uniquely position them to be the preeminent provider of insurance and financial services in the U.S.”
Insitutional Activity: The institutional sentiment decreased to 0.93 in Q2 2016. Its down 0.11, from 1.04 in 2016Q1. The ratio is negative, as 55 funds sold all Metlife Inc shares owned while 343 reduced positions. 81 funds bought stakes while 334 increased positions. They now own 797.11 million shares or 0.92% less from 804.49 million shares in 2016Q1.
Private Advisor Grp Incorporated has invested 0.08% of its portfolio in Metlife Inc (NYSE:MET). The New York-based Atalanta Sosnoff Capital Ltd Liability Corp has invested 0.05% in Metlife Inc (NYSE:MET). Foster And Motley Inc holds 16,118 shares or 0.13% of its portfolio. Seabridge Inv Ltd Liability Com accumulated 400 shares or 0% of the stock. Checchi Advisers Limited Liability Corporation has 0.03% invested in the company for 7,464 shares. Budros Ruhlin And Roe holds 0.21% or 15,374 shares in its portfolio. Peddock Capital Ltd Liability Corp has invested 0.24% of its portfolio in Metlife Inc (NYSE:MET). Moreover, First Niagara Bancshares has 0.33% invested in Metlife Inc (NYSE:MET) for 28,898 shares. Lingohr And Partner Asset Gmbh holds 1.11% of its portfolio in Metlife Inc (NYSE:MET) for 27,695 shares. Utd Fire Gp last reported 1,800 shares in the company. Moreover, Cutter & Company Brokerage has 0.13% invested in Metlife Inc (NYSE:MET) for 7,882 shares. Hexavest Inc last reported 0.87% of its portfolio in the stock. Dreman Value Mgmt L L C holds 1.13% of its portfolio in Metlife Inc (NYSE:MET) for 45,944 shares. Capital Returns Mgmt Ltd Liability Corporation last reported 5.2% of its portfolio in the stock. Benjamin F Edwards And Com accumulated 0.2% or 25,225 shares.
More important recent Metlife Inc (NYSE:MET) news were published by: Businesswire.com which released: “MetLife Declares Fourth Quarter 2016 Preferred Stock Dividends” on November 15, 2016, also Businesswire.com published article titled: “MetLife to Hold Investor Outlook Call”, Investorplace.com published: “Metlife Inc (MET) Is Starting Its Run” on November 17, 2016. More interesting news about Metlife Inc (NYSE:MET) was released by: Wsj.com and their article: “MetLife Resumes Buybacks With Its Largest Ever, for $3 Billion” with publication date: November 10, 2016.
MET Company Profile
MetLife, Inc. (MetLife), incorporated on August 10, 1999, is a well-known provider of life insurance, annuities, employee benefits and asset management. The Company’s divisions include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA). In addition, MetLife’s Corporate & Other contains the surplus portfolios for the enterprise, the portfolios used to fund the capital needs of the Company and various reinsurance agreements. In the United States, the Company provides a range of insurance and financial services products, including life, dental, disability, property and casualty, guaranteed interest, stable value and annuities, through both proprietary and independent retail distribution channels, as well as at the workplace. Outside the United States, the Company provides life, medical, dental, credit and other accident and health insurance, as well as annuities, endowment and retirement and savings products to both individuals and groups.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.